PORPHYRIA-CUTANEA-TARDA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA

被引:15
|
作者
GUYOTAT, D
NICOLAS, JF
AUGEY, F
FIERE, D
THIVOLET, J
机构
[1] HOP EDOUARD HERRIOT,DERMATOL CLIN,F-69374 LYONS 08,FRANCE
[2] HOP EDOUARD HERRIOT,UNITE GREFFES MOELLE OSSEUSE,F-69374 LYONS 08,FRANCE
关键词
cytomegalovirus infection; hepatic porphyria; immune deficiency;
D O I
10.1002/ajh.2830340115
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A case of porphyria cutanea tarda (PCT) occurring after bone marrow transplantation (BMT) is reported. A 43‐year‐old male with chronic myelogenous leukemia received an human leukocyte antigen (HLA)‐identical allogeneic transplantation with T‐cell depleted marrow. Because of graft rejection, a second transplant was performed 4 months later. A grade II acute graft‐ vs.‐host disease and a cytomegalovirus (CMV) infection were subsequently observed. Two years after the second transplant, cutaneous symptoms of PCT with typical biochemical abnormalities developed. Liver biopsy revealed signs of hepatitis with iron overload. CMV was isolated from liver tissue. The possible roles of underlying disease, BMT, and CMV liver disease are discussed in view of the recently reported cases of PCT in patients with AIDS or hematological disorders. Copyright © 1990 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:69 / 70
页数:2
相关论文
共 50 条
  • [21] BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
    GOLDMAN, JM
    BORTIN, MM
    CHAMPLIN, RE
    HERZIG, RH
    MCGLAVE, PB
    MESSNER, HA
    RIMM, AA
    SPECK, B
    WEINER, RS
    LANCET, 1985, 2 (8467): : 1295 - 1295
  • [22] ALLOGENEIC BONE-MARROW TRANSPLANT IN CHRONIC MYELOGENOUS LEUKEMIA
    SPECK, B
    GRATWOHL, A
    NISSEN, C
    OSTERWALDER, B
    MULLER, M
    BANNERT, P
    MULLER, HJ
    JEANNET, M
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1982, 112 (41) : 1419 - 1420
  • [23] ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA - PESCARA TEAM EXPERIENCE
    DIGIROLAMO, G
    DIBARTOLOMEO, P
    NATALE, D
    IACONE, A
    MUZIL, G
    PROSPERINI, G
    TORLONTANO, G
    EXPERIMENTAL HEMATOLOGY, 1985, 13 : 93 - 93
  • [24] KARYOTYPE AT RELAPSE FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
    SHAH, NK
    WAGNER, J
    SANTOS, G
    GRIFFIN, CA
    CANCER GENETICS AND CYTOGENETICS, 1992, 61 (02) : 183 - 192
  • [25] CHRONIC SCARRING DERMATOSES - REMEMBER PORPHYRIA-CUTANEA-TARDA
    ADOGU, AA
    TROPICAL DOCTOR, 1992, 22 (02) : 93 - 94
  • [26] IMMUNOLOGICAL RECONSTITUTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION OF PATIENTS WITH MYELOGENOUS LEUKEMIA
    SAAL, JG
    SCHNEIDER, F
    SCHNEIDER, M
    SCHMIDT, H
    DOPFER, R
    EHNINGER, G
    BLUT, 1987, 55 (04): : 382 - 382
  • [27] PORPHYRIA-CUTANEA-TARDA IN A PATIENT WITH HAIRY-CELL LEUKEMIA
    HACKER, SM
    BERKWITZ, M
    CODY, R
    CUTIS, 1993, 51 (04): : 251 - 252
  • [28] 5Q- IN A CASE OF CHRONIC MYELOGENOUS LEUKEMIA RELAPSED AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    SOLIGO, D
    ROMITTI, L
    BERTOLLI, V
    VOLPE, AD
    ANNALORO, C
    DELILIERS, GL
    HAEMATOLOGICA, 1995, 80 (05) : 437 - 439
  • [29] JUVENILE CHRONIC MYELOGENOUS LEUKEMIA - IN-VITRO CHARACTERIZATION BEFORE AND AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    ZECCA, M
    ROSTI, V
    PINTO, L
    COMOLI, P
    CARRA, AM
    PRETE, L
    BONETTI, F
    PEDRAZZOLI, P
    LOCATELLI, F
    CAZZOLA, M
    MEDICAL AND PEDIATRIC ONCOLOGY, 1995, 24 (03): : 166 - 170
  • [30] BONE-MARROW TRANSPLANTATION IN CHRONIC MYELOGENOUS LEUKEMIA - REPLY
    THOMAS, ED
    FEFER, A
    NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (22): : 1364 - 1365